MapLight Therapeutics, Inc. Common Stock
MPLTNASDAQHEALTHCARE
About MapLight Therapeutics, Inc. Common Stock
MapLight Therapeutics, Inc. is an innovative biotechnology company that is dedicated to developing groundbreaking therapies for complex neurological and psychiatric disorders. Utilizing a proprietary platform, MapLight focuses on intricate biological pathways to create transformative treatment solutions aimed at significantly enhancing patient outcomes. With a robust commitment to scientific rigor and a promising clinical pipeline, the company is strategically positioned to meet critical unmet medical needs, establishing itself as a potential leader in the dynamic neurotherapeutics sector.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- USA
- Fiscal year end
- December
- Website
- maplightrx.com
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.